Oklahoma HB 3174: Public health; providing for the establishment of statewide investigational new drug applications for psilocybin clinical trials; effective date.

Status: Second Reading referred to Rules (as of 2022-02-08)

State: Oklahoma · Session: 2022 · Bill: HB 3174

Sponsors: Phillips

View Oklahoma HB 3174 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.